Novocure Limited (NASDAQ: NVCR ) develops wearables that generate Tumor Treating Fields (TTFields), which can be used for treating aggressive cancers. In that sense, NVCR features approved devices like Optune and Optune Gio for treating glioblastoma (GBM). NVCR’s Optune Lua instead helpsMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athen ...